CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.

As CVS Health has significantly outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Leaving the Obamacare exchange, closing some Oak Street clinics and taking a $5.7 billion charge have CVS Health on a better financial path.

Starting this month, 68 OTC products will debut in new packaging under the CVS product brand (formerly the CVS Health brand). CVS said that as consumers continue to favor brands that simplify decision ...

Whether you're an avid shopper or someone who visits only when they need a prescription filled, you can cash in big with the ...

Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion ...

Discover why CVS Health Corporation is rated a Buy, offering 18% upside, robust growth, and a 3.25% yield. Click for more on ...

Q3 2025 Earnings Call Transcript October 29, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.6, ...

The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention breakthrough, at least for now. CVS Health, the parent of PBM juggernaut CVS ...

CVS Pharmacy has finalized the acquisition of select Rite Aid and Bartell Drugs assets, marking a major expansion of its ...

July 15 (Reuters) - CVS Health Corp (CVS.N), opens new tab said on Thursday it had halted the sales of two of its sunburn products, citing an abundance of caution, without providing further details.

One of the biggest retail chains in the country, CVS Caremark, announced today that it will stop selling cigarettes, cigars and chewing tobacco at its more than 7,600 stores by October 1, trading in ...